Personalized Medicine – Multimedia

Download this infographic to learn more about what cell and gene therapies are, how they are made, and advancements and future considerations in cell and gene therapy research.

Speaking at the online symposium, Innovations in Disease Modeling 2022, Dr. Donald E. Ingber, Founding Director of Wyss Institute for Biologically Inspired Engineering at Harvard University, presented his talk on novel human organ-on-a-chip technologies

Speaking at the Innovations in Disease Modeling online symposium, Steven Broadbent delivered his talk on the use of human iPSC-derived cells in disease modeling.

Download this eBook to learn more about finding proteins that cause disease, how proteomics enriches the multiomic study of disease as well as the future of proteomics in multionmics research.

In this episode of TSE explores we will be speaking to Dr Julia Steinberg.

Technological advances along with developments in molecular medicine and data science have fueled the exploration of personalized medicine, as a result, several fields are already benefiting. Download this eBook to learn more about the topic.

The use of organoids, self-organized three-dimensional (3D) assemblies of cells, as research tools has become more common due to their ability to better recapitulate human disease compared to more traditional models.

In this Teach Me in 10, we are joined by Dr. Clare Paterson from SomaLogic. Dr. Paterson discusses the power of proteomics, exploring how proteomics has evolved from assessments of single analytes to sensitive, specific and high throughput technologies capable of generating a wealth of invaluable data.

Gene therapy is an effective tool for modifying genetic material within a cell. This pioneering form of precision medicine addresses health conditions caused by mutated, faulty or malfunctioning genes within cells.

Download this eBook to learn more about identifying new treatments, using in vitro and in vivo models for drug screening as well as predicting patient drug responses to cancer organoids.